£156.70

Wiley-Blackwell The Peripheral T-Cell Lymphomas

Price data last checked 38 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£157 today · cheaper than every other day in the last 2 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 16 days · 16 data points (no recent data)

Historical
Generating forecast…
£156.70 £148.86 £152.00 £155.13 £158.27 £161.40 £164.54 01 June 2026 04 June 2026 08 June 2026 12 June 2026 16 June 2026

Price Distribution

Price distribution over 16 days • 1 price levels

Days at Price
16 days 0 4 8 12 16 £157 Days at Price

Price Analysis

Most common price: £157 (16 days, 100.0%)

Price range: £157 - £157

Price levels: 1 different prices over 16 days

Description

THE PERIPHERAL T-CELL LYMPHOMASProvides a comprehensive look at Peripheral T-Cell lymphomas, including the group’s unique geographic distribution, underlying genetics, and novel treatmentsPeripheral T-Cell lymphomas (PTCL) are a diverse group of lymphoid malignancies that develop from mature T cells and natural killer (NK) cells. PTCL represent 10-15% of all cases of non-Hodgkin lymphoma in the US, and up to 20-25% of cases in South America, Asia, and other regions around the world. The role of different etiologic factors and the variation of geographic distribution makes PTCL one of the most difficult types of cancer to understand and treat. For the first time in a single volume, The Peripheral T-Cell Lymphomas presents a comprehensive survey of this complex and rare group of blood cancers. Featuring contributions from an international team of leading authorities in the various aspects of PTCL, this authoritative text covers biology, epidemiology, classification, approved and emerging drugs, molecular genetics, and more. Detailed clinical chapters address diagnosis, prognosis, and treatment of each of the major PTCL subtypes identified in the 2018 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. This much-needed resource: Covers the biological basis, epidemiology, classification, and treatment of PTCLDiscusses the future of the field, including global collaboration efforts and novel approaches to PCTLExplores the role of biologics in PTCL and autologous and allogeneic stem-cell transplantationOffers new insights on molecular pathogenesis, innovative therapeutics, and novel drug combinationsFeatures contributions from the Chairs The T-Cell Lymphoma Forum: the world’s largest meeting focused on PTCLReflecting the unique epidemiology and genetic diversity of the PTCL, The Peripheral T-Cell Lymphomas is an indispensable source of data, insight, and references for the medical community, particularly oncologists and hematologists in both training and practice. From the Inside Flap Provides a comprehensive look at Peripheral T-Cell lymphomas, including the group’s unique geographic distribution, underlying genetics, and novel treatmentsPeripheral T-Cell lymphomas (PTCL) are a diverse group of lymphoid malignancies that develop from mature T cells and natural killer (NK) cells. PTCL represent 10-15% of all cases of non-Hodgkin lymphoma in the US, and up to 20-25% of cases in South America, Asia, and other regions around the world. The role of different etiologic factors and the variation of geographic distribution makes PTCL one of the most difficult types of cancer to understand and treat. For the first time in a single volume, The Peripheral T-Cell Lymphomas presents a comprehensive survey of this complex and rare group of blood cancers. Featuring contributions from an international team of leading authorities in the various aspects of PTCL, this authoritative text covers biology, epidemiology, classification, approved and emerging drugs, molecular genetics, and more. Detailed clinical chapters address diagnosis, prognosis, and treatment of each of the major PTCL subtypes identified in the 2018 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. This much-needed resource: Covers the biological basis, epidemiology, classification, and treatment of PTCLDiscusses the future of the field, including global collaboration efforts and novel approaches to PCTLExplores the role of biologics in PTCL and autologous and allogeneic stem-cell transplantationOffers new insights on molecular pathogenesis, innovative therapeutics, and novel drug combinationsFeatures contributions from the Chairs The T-Cell Lymphoma Forum: the world’s largest meeting focused on PTCLReflecting the unique epidemiology and genetic diversity of the PTCL, The Peripheral T-Cell Lymphomas is an indispensable source of data, insight, and references for the medical community, particularly oncologists and he

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
11 May 2021
Listed Since
16 August 2020

Barcode

No barcode data available

Similar Products You Might Like

Adult T-cell Leukemia/Lymphoma
97% match

Adult T-cell Leukemia/Lymphoma

Springer

£99.03 12 Jun 2026
Ioachim's Lymph Node Pathology
97% match

Ioachim's Lymph Node Pathology

Lippincott Williams & Wilkins

£201.19 11 Jul 2026
Diagnostic Pathology: Blood and Bone Marrow
97% match

Diagnostic Pathology: Blood and Bone Marrow

Elsevier

£186.15 16 Jun 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£248.00 17 Jun 2026
T-Cell Lymphomas (Contemporary Hematology)
97% match

T-Cell Lymphomas (Contemporary Hematology)

Humana

£80.66 02 Jul 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£401.90 16 Jun 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
96% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.39 15 Jul 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£430.64 13 Jun 2026
T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)
96% match

T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)

Springer

£107.85 24 Jul 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
96% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£76.09 24 Jul 2026
Manual of Hematopoietic Cell Transplantation and Cellular Therapies
96% match

Manual of Hematopoietic Cell Transplantation and Cellular Therapies

Elsevier

£158.99 10 Jun 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
96% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£71.02 04 Jul 2026
Clinical Malignant Hematology
96% match

Clinical Malignant Hematology

McGraw-Hill Education

£201.99 17 Jun 2026
Chronic Lymphoid Leukemias: 26 (Basic and Clinical Oncology)
96% match

Chronic Lymphoid Leukemias: 26 (Basic and Clinical Oncology)

CRC Press

£94.60 11 Jun 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
96% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£122.54 04 Jul 2026
The WHO Classification of Tumours Haematolymphoid Tumours (Volume 11) 5th edition
96% match

The WHO Classification of Tumours Haematolymphoid Tumours (Volume 11) 5th edition

World Health Organization

£158.09 20 Jun 2026
Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas
96% match

Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas

Elsevier

£198.73 20 Jun 2026
Atlas of Hematologic Neoplasms
96% match

Atlas of Hematologic Neoplasms

Springer

£188.80 13 Jun 2026
Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver
96% match

Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver

Springer

£73.57 06 Jul 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
96% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£91.75 17 Jul 2026
The MD Anderson Manual of Medical Oncology, Fourth Edition
96% match

The MD Anderson Manual of Medical Oncology, Fourth Edition

McGraw-Hill Education

£181.41 17 Jun 2026
Advances in Cancer Research: 84: Volume 84
96% match

Advances in Cancer Research: 84: Volume 84

Academic Press

£29.20 09 Jul 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£150.48 13 May 2026
Precision Cancer Therapies, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice: 1 (Precision Cancer Therapies, Volume 1)
96% match

Precision Cancer Therapies, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice: 1 (Precision Cancer Therapies, Volume 1)

Wiley-Blackwell

£117.43 17 Jul 2026